Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada.

Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault.

In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.

You can help Wikipedia by expanding it.This article about a Canadian corporation or company is a stub.